Insider · CIK 0001614997
Bruce D. Steel
Files at EQ (Equillium, Inc.). First filing -, latest -.
In brief
Bruce D. Steel files SEC Form 4 as CEO, president, director and 10% owner at EQ (Equillium, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Bruce D. Steel has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +1,750,000 | $0.00 | $0 | 1,750,000 | Jan 9, 2026 |
| Aug 29, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +1,695,000 | $0.00 | $0 | 1,695,000 | Sep 3, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +44,352 | - | - | 44,352 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -44,352 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +100,000 | - | - | 100,000 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -100,000 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +60,000 | - | - | 60,000 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -60,000 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +100,110 | - | - | 100,110 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -100,110 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +245,000 | - | - | 245,000 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -245,000 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +325,000 | - | - | 325,000 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -325,000 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +410,000 | - | - | 410,000 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -410,000 | - | - | 0 | Feb 19, 2025 |
| Jan 2, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +410,000 | $0.00 | $0 | 410,000 | Jan 6, 2025 |
Questions about Bruce D. Steel
Answered from the filings on this page, as of the latest one.
Is Bruce D. Steel buying or selling?
Bruce D. Steel has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Bruce D. Steel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bruce D. Steel has 0.
Where does Bruce D. Steel file Form 4?
Bruce D. Steel has filed Form 4 at EQ (Equillium, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.